Luminor Medical Technologies is a medical diagnostic company, focuses on acquiring, developing, and commercializing non-invasive tests for unmet clinical needs in Canada. The company’s products and services include PREVU Skin Cholesterol Test, a non-invasive test that measures cholesterol in the skin tissues to assess risk of coronary artery disease or heart disease; PSP94, an enzyme linked immunosorbent assay for urine specimens; and testing services. Its diagnostic programs under development comprise cardiovascular disease, preeclampsia, prostate cancer, colorectal cancer, pancreatic cancer, and gastric cancer programs. The company has a partnership agreement with Alere, Inc. for the development of tests for preeclampsia biomarkers.
VeraLight is a medical device company founded in October 2004, specializing in non-invasive screening for type 2 diabetes and pre-diabetes through its proprietary SCOUT DS system. The company aims to combat the global diabetes epidemic by promoting early detection, which can lead to timely interventions that prevent the onset of diabetes and mitigate its complications. VeraLight focuses on developing and acquiring innovative technologies, products, and services that align with its mission to improve diabetes management and patient outcomes.
Europroteome AG
Acquisition in 2005
Europroteome AG develops diagnostic, immunological, and prognostic tools as well as patient-specific therapies for human epithelial cancers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.